Ultrasound-Activated Neuropeptide Delivery Across the Blood-Brain Barrier | Research

The takeaway

Ultrasound-actuated delivery enabled neuropeptide transport across cerebrovascular interfaces, demonstrating a non-invasive method for brain-targeted peptide therapeutics.

Sound opens brain barrier
Focused ultrasound temporarily opens the BBB, enabling neuropeptides to reach specific brain regions non-invasively

What the researchers found

Ultrasound actuated neuropeptide delivery across cerebrovascular interfaces, demonstrating non-invasive, region-specific brain-targeted peptide therapeutics.

Why it matters

Brain disorders need peptide therapies but the BBB blocks them. Ultrasound provides a non-invasive solution for targeted brain delivery.

How the study worked

Ultrasound-mediated BBB opening for neuropeptide delivery, with transport characterization across cerebrovascular interfaces.

What this study cannot tell us

Preclinical. BBB opening must be transient and safe. Neuropeptide stability during ultrasound exposure needs verification.

How to read the evidence

Proof-of-concept for ultrasound-mediated brain peptide delivery.

When this study was published

Published in 2025.

The bigger picture

Ultrasound-guided brain drug delivery could transform treatment of neurological diseases by enabling peptide therapeutics to reach their brain targets.

Questions still open

Could this deliver GLP-1 drugs directly to brain appetite centers?
Is repeated ultrasound BBB opening safe long-term?
Which neuropeptide disorders would benefit most?

Common questions

How can ultrasound help deliver brain drugs?

Focused ultrasound temporarily opens tiny gaps in the blood-brain barrier, allowing therapeutic peptides to pass through. The opening is reversible and can be targeted to specific brain areas.

Is this safe?

The BBB opening is temporary and localized. Safety studies are ongoing, but the approach shows promise for non-invasive brain drug delivery without surgery.

Read the original research

Ultrasound actuated neuropeptide delivery across cerebrovascular interfaces using phase-change peptide nanoemulsions.

Journal of colloid and interface science, 705, 139466

View on PubMed ↗Publisher’s paper ↗

Citation

Kim, Inhye; Griffith, Keith; Brockway, Dakota F; Crowley, Nicole A; Medina, Scott H. (2026). Ultrasound actuated neuropeptide delivery across cerebrovascular interfaces using phase-change peptide nanoemulsions.. Journal of colloid and interface science, 705, 139466. https://doi.org/10.1016/j.jcis.2025.139466